OncoTherapy Science, Inc.
4564.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -¥815,285 | -¥1,288,138 | -¥1,116,420 | -¥2,570,306 |
| Dep. & Amort. | ¥0 | ¥0 | ¥0 | ¥16,540 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥545,377 |
| Stock-Based Comp. | ¥0 | ¥7,655 | ¥31,335 | ¥39,384 |
| Change in WC | -¥74,983 | -¥90,284 | ¥339,752 | -¥61,048 |
| Other Non-Cash | ¥75,247 | ¥142,777 | -¥49,568 | -¥43,171 |
| Operating Cash Flow | -¥815,021 | -¥1,227,990 | -¥794,901 | -¥2,073,224 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥279 | -¥2,627 | -¥5,393 | -¥456,949 |
| Net Acquisitions | ¥0 | ¥0 | ¥476 | ¥49 |
| Inv. Purchases | ¥0 | ¥0 | ¥0 | ¥0 |
| Inv. Sales/Matur. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Inv. Act. | ¥0 | -¥30,727 | -¥15,402 | -¥11,028 |
| Investing Cash Flow | -¥279 | -¥33,354 | -¥20,319 | -¥467,928 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -¥55,672 | -¥4,642 | ¥0 | ¥0 |
| Stock Issued | ¥1,174,772 | ¥682,552 | ¥0 | ¥1,466,717 |
| Stock Repurch. | -¥1,350 | ¥0 | ¥0 | ¥0 |
| Dividends Paid | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Fin. Act. | ¥6,207 | -¥5 | ¥95,950 | ¥12,250 |
| Financing Cash Flow | ¥1,121,527 | ¥671,365 | ¥95,950 | ¥1,478,967 |
| Forex Effect | ¥0 | ¥0 | -¥1 | -¥1 |
| Net Chg. in Cash | ¥306,227 | -¥589,979 | -¥719,271 | -¥1,062,186 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥527,656 | ¥1,117,635 | ¥1,836,906 | ¥2,899,092 |
| End Cash | ¥833,883 | ¥527,656 | ¥1,117,635 | ¥1,836,906 |
| Free Cash Flow | -¥815,300 | -¥1,230,617 | -¥800,294 | -¥2,530,173 |